BSE filing, NSE: PHARMAID. Summary written from the filing by ALFA Finder's alert engine.
Pharmaids Pharmaceuticals Ltd: key numbers
- Share price
- ₹28.42
- Market cap
- ₹100.2 Cr
- Revenue (annual)
- ₹27.88 Cr
- Net profit (annual)
- ₹-11.72 Cr
- P/E (TTM)
- -22.0×Sector 48.7×
- Promoter holding
- 32.99%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pharmaids Pharmaceuticals Ltd
All →Pharmaids Pharmaceuticals Other Announcement
Pharmaids Pharmaceuticals Limited filed its quarterly Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent confirming the dematerialization of shares.
Pharmaids Pharmaceuticals Legal & Regulatory
Pharmaids Pharmaceuticals filed legal complaints against Anugraha Chemicals for dishonoured cheques totalling ₹2.63 Crore in outstanding dues from a disinvestment agreement.
- Value
- ₹2.63 Cr
Pharmaids Pharmaceuticals Annual General Meeting
Pharmaids Pharmaceuticals held its 37th AGM via video conference on 11 Sept 2026. Four resolutions including adoption of FY26 financials and related-party-transaction approvals were tabled.
Pharmaids Pharmaceuticals Promoter Buying (Off-Market)
KMP Prasanna Subramanya Bhat acquired 17,291 shares of Pharmaids Pharmaceuticals Ltd via a gift from an immediate relative. This off-market transfer is an insider disclosure.
- Promoter stake change
- +0.04%
Pharmaids Pharmaceuticals Annual General Meeting
Pharmaids Pharmaceuticals Limited has issued the notice for its 37th Annual General Meeting, scheduled for September 11, 2026, along with the Annual Report for 2025-26.
Pharmaids Pharmaceuticals Q1 FY27 Results: Net Profit ₹1.9 Cr, Down 64.2% YoY
Pharmaids Pharmaceuticals Ltd reported revenue from operations of ₹4.1 Cr (-38.8% YoY) and net profit of ₹1.9 Cr (-64.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.9 Cr · -64.2% YoY
Other management change announcements
All →Suryoday Small Finance Bank Management Change
Suryoday Small Finance Bank announced that Mr. Ranjit Jayant Shah, Non-Executive Non-Independent Director, will cease to hold office effective November 2, 2026, upon tenure completion.
CARE Ratings Management Change
CARE Ratings Limited appointed Mr. Jatindar Pal Singh Bajaj as a Non-Executive Non-Independent Director, effective October 29, 2026.
Alldigi Tech Management Change
Alldigi Tech appointed Alok Kumar Chaubey as Vice President - Sales, effective 29 October 2026. He brings over 15 years of HR Tech SaaS experience.
Indegene Management Change
Indegene's Company Secretary and Compliance Officer Srishti Ramesh Kaushik resigned, effective 02-Dec-2026. The resignation cites future career advancement.
EPACK Durables Management Change
EPACK Durable's CFO, Rajesh Kumar Mittal, resigned citing personal reasons, effective October 31, 2026. The resignation was disclosed alongside board meeting outcomes held October 29, 2026.
Qualitek Labs Management Change
Qualitek Labs' Independent Director Ajay Agarwal resigned effective October 29, 2026, citing personal reasons. He was not on any board committee, so no reconstitution is required.